Agilent Technologies, Inc. (BVMF:A1GI34)

Brazil flag Brazil · Delayed Price · Currency is BRL
281.12
0.00 (0.00%)
At close: May 19, 2026
Market Cap158.03B -9.7%
Revenue (ttm)37.01B +8.1%
Net Income6.76B +2.5%
EPS23.73 +3.9%
Shares Outn/a
PE Ratio23.39
Forward PE17.98
Dividend1.69 (0.62%)
Ex-Dividend DateMar 30, 2026
Volume1
Average Volume5
Open281.12
Previous Closen/a
Day's Range281.12 - 281.12
52-Week Range274.17 - 410.72
Beta1.22
RSI31.30
Earnings DateMay 27, 2026

About Agilent Technologies

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnosti... [Read more]

Sector Healthcare
Founded 1999
Employees 18,000
Stock Exchange Brazil Stock Exchange
Ticker Symbol A1GI34

Financial Performance

In fiscal year 2025, Agilent Technologies's revenue was $6.95 billion, an increase of 6.73% compared to the previous year's $6.51 billion. Earnings were $1.30 billion, an increase of 1.09%.

Financial numbers in USD Financial Statements

News

Agilent Announces Cash Dividend of 25.5 Cents per Share

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 25.5 cents per share of common stock. The quarterly di...

5 hours ago - Business Wire

Agilent to supply Bulk Alarm Resolution Technology to U.S. airport security

Agilent (A) Technologies announced that it has been awarded a contract by the Transportation Security Administration, TSA, and will deploy its new Bulk Alarm Resolution Technology, BRT, to security ch...

1 day ago - TheFly

Agilent to Supply Next Generation Alarm Resolution Technology to U.S. Airport Security Screening Checkpoints ahead of FIFA World Cup 2026

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that it has been awarded a contract by the Transportation Security Administration (TSA) and will deploy its ne...

1 day ago - Business Wire

Agilent to Participate in Jefferies Global Healthcare Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will participate in a fireside chat at the Jefferies Global He...

9 days ago - Business Wire

Agilent appoints Michael Buckner as CLO

Agilent Technologies (A) announced the appointment of Michael Buckner as chief legal officer. Buckner joins Agilent from Danaher Corp. (DHR), where he served as vice president, deputy general counsel,...

16 days ago - TheFly

Agilent Names Michael Buckner as Chief Legal Officer

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) today announced the appointment of Michael Buckner as chief legal officer, effective today. Bu...

16 days ago - Business Wire

Agilent to Announce Second-Quarter Fiscal Year 2026 Financial Results on May 27

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) will release financial results for the second quarter of fiscal year 2026 after the stock mark...

22 days ago - Business Wire

Labcorp announces availability of Agilent’s PD-L1 IHC 22C3 pharmDx

Labcorp (LH) announced the nationwide availability of Agilent Technologies’ (A) PD-L1 IHC 22C3 pharmDx, the only companion diagnostic approved by the U.S. FDA to identify patients with platinum-resist...

4 weeks ago - TheFly

Axion BioSystems and Agilent Technologies Resolve Litigation

ATLANTA--(BUSINESS WIRE)--Axion BioSystems, Inc., a leading provider of live-cell analysis technologies, today announced that Agilent Technologies, Inc. and Axion BioSystems have fully resolved the is...

4 weeks ago - Business Wire

Agilent showcases cancer research solutions at AACR 2026

Agilent (A) Technologies will present new technologies, scientific collaborations, and integrated workflows supporting cancer research and diagnostics at the American Association for Cancer Research A...

5 weeks ago - TheFly

Agilent Showcases Cancer Research Solutions at AACR 2026

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will present new technologies, scientific collaborations, and integrated workflows supporting cancer research and diagnostics ...

5 weeks ago - Business Wire

Agilent price target lowered to $140 from $150 at Barclays

Barclays analyst Luke Sergott lowered the firm’s price target on Agilent (A) to $140 from $150 and keeps an Overweight rating on the shares. The firm adjusted targets in the…

5 weeks ago - TheFly

Agilent price target lowered to $140 from $160 at Evercore ISI

Evercore ISI lowered the firm’s price target on Agilent (A) to $140 from $160 and keeps an Outperform rating on the shares as part of the firm’s medical technology and…

6 weeks ago - TheFly

Agilent announces BioTek Cytation 9 cell imaging multimode reader

Agilent (A) Technologies announced the launch of the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation portfolio combining multimode microplate reading and high-cont...

7 weeks ago - TheFly

Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced the launch of the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation portfo...

7 weeks ago - Business Wire

Agilent Technologies Slides: Corporate presentation

Agilent Technologies has posted slides in relation to its latest quarterly earnings report, which was published on March 27, 2026.

7 weeks ago - Filings

Agilent receives FDA approval for PD-L1 1HC 22C3 pharmDx

Agilent Technologies (A) announced that it has received U.S. Food and Drug Administration approval for PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to aid in identifying patients…

7 weeks ago - TheFly

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that it has received U.S. Food and Drug Administration (FDA) approval for PD-L1 IHC 22C3 pharmDx, Code SK006, ...

7 weeks ago - Business Wire

Agilent upgraded to Buy from Hold at Nephron Research

Nephron Research analyst Jack Meehan upgraded Agilent (A) to Buy from Hold with a $145 price target

7 weeks ago - TheFly

Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it will feature its latest advances in precision oncology and digital pathology workflows at the 2026 United S...

2 months ago - Business Wire

Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent Advanced Therapeutics, a unified Contract Development an...

2 months ago - Business Wire

Citi opens ‘upside 90-day catalyst watch’ on Agilent

Citi opened an “upside 90-day catalyst watch” on shares of Agilent (A) while keeping a Buy rating on the name with a $185 price target The share overhang of a…

2 months ago - TheFly

Agilent to acquire Biocare Medical for $950M in cash

Agilent (A) announced it has entered into a definitive agreement to acquire Biocare Medical from an investor group led by Excellere Partners and GHO Capital Partners, in an all-cash transaction…

2 months ago - TheFly

M&A News: Agilent to Buy Biocare Medical for $950M — What Investors Should Know

Agilent Technologies ($A) announced that it will acquire Biocare Medical in a $950 million all-cash deal, aiming to strengthen its position in the fast-growing pathology and cancer diagnostics market....

2 months ago - TipRanks

Agilent to acquire Biocare Medical in $950 million all-cash deal

Life ​sciences firm ‌Agilent Technologies ​said ​on Monday ⁠that ​it ​will acquire clinical ​pathology ​firm Biocare Medical ‌in ⁠an all-cash ​deal ​valued ⁠at $950 million.

2 months ago - Reuters